Fred Hutchinson Cancer Research Center

OverviewSuggest Edit

Fred Hutchinson Cancer Research Center is a nonprofit research institute that provides services for the prevention, diagnosis, and treatment of cancer, HIV/AIDS, and other life-threatening diseases. It is engaged in generating new scientific discoveries, supporting and training scientists, promoting the importance of scientific research, responsible medical care, healthy environments, etc.
TypePrivate
Founded1975
HQSeattle, US
Websitefredhutch.org
Employee Ratings3.9
Overall CultureA+

Latest Updates

Employees (est.) (Nov 2020)4,474
Job Openings180
Revenue (FY, 2019)$714 M(-17%)
Cybersecurity ratingCMore

Key People/Management at Fred Hutchinson Cancer Research Center

Niki Robinson

Niki Robinson

Vice President and Deputy Chief Operating Officer
Thomas J. Lynch

Thomas J. Lynch

President and Director
Kathy Surace-Smith

Kathy Surace-Smith

Chair
Adam Geballe

Adam Geballe

Associate Director, Human Biology Division
Christy Majorowicz

Christy Majorowicz

Associate Operations Director, Basic Sciences Division
Sarah Martien

Sarah Martien

Senior Operations Director, Vaccine and Infectious Disease Division
Show more

Fred Hutchinson Cancer Research Center Office Locations

Fred Hutchinson Cancer Research Center has offices in Seattle, Cape Town and Kampala
Seattle, US (HQ)
1100 Fairview Ave N j5
Seattle, US
1205 Aloha St
Seattle, US
820 Minor Ave N
Seattle, US
823 Yale Ave N
Cape Town, ZA
40 Solan Rd, Gardens
Kampala, UG
Mulago Hospital, Upper Mulago Hill Road
Show all (6)

Fred Hutchinson Cancer Research Center Financials and Metrics

Summary Metrics

Founding Date

1975
Show all financial metrics

Fred Hutchinson Cancer Research Center Revenue

Fred Hutchinson Cancer Research Center's revenue was reported to be $713.96 m in FY, 2019 which is a 17.4% decrease from the previous period.
USD

Revenue (FY, 2019)

714.0m

Revenue growth (FY, 2018 - FY, 2019), %

(17.4%)

Net income (FY, 2019)

98.6m

EBIT (FY, 2019)

65.1m

Cash (30-Jun-2019)

22.3m
USDFY, 2017FY, 2018FY, 2019

Revenue

555.1m864.3m714.0m

Revenue growth, %

56%(17%)

General and administrative expense

70.7m84.1m88.2m

R&D expense

443.7m500.4m543.0m
USDFY, 2017FY, 2018FY, 2019

Cash

12.6m32.7m22.3m

Accounts Receivable

31.7m30.6m49.1m

PP&E

379.4m379.8m380.6m

Total Assets

973.1m1.2b1.3b
USDFY, 2017FY, 2018FY, 2019

Net Income

11.0m233.6m98.6m

Depreciation and Amortization

24.9m26.2m28.6m

Accounts Payable

(2.8m)3.1m(2.8m)

Cash From Operating Activities

(1.5m)103.9m3.9m
USDFY, 2017

Debt/Equity

0.7 x

Debt/Assets

0.4 x

Financial Leverage

2 x
Show all financial metrics

Fred Hutchinson Cancer Research Center Operating Metrics

Nov, 2020

Active Inventions

385

Clinical Trials

454

Laboratories Space, sq. ft.

250 k
Show all operating metrics

Fred Hutchinson Cancer Research Center Revenue Breakdown

Embed Graph

Fred Hutchinson Cancer Research Center revenue breakdown by business segment: 65.2% from Research Grants and Contracts, 7.6% from Contributions, 6.1% from Investment Income and Realized Gains and Losses, 10.3% from IP Commercialization Income, 7.8% from Other Income and 2.9% from Other

Fred Hutchinson Cancer Research Center Cybersecurity Score

Cybersecurity ratingPremium dataset

C

78/100

SecurityScorecard logo

Fred Hutchinson Cancer Research Center Online and Social Media Presence

Embed Graph

Fred Hutchinson Cancer Research Center Company Culture

  • Overall Culture

    A+

    83/100

  • CEO Rating

    A+

    85/100

  • Compensation

    A-

    79/100

Learn more on Comparably

Fred Hutchinson Cancer Research Center News and Updates

New protocols, precision approaches ahead for lung cancer

Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients

Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more

red Hutchinson Cancer Research Center’s latest findings on cell therapies, repairing immune function, and more will be featured at the 62nd American Society of Hematology Annual Meeting & Exposition, to be held virtually Dec. 5 – 8

New Fred Hutch-led trial shows no benefits of dairy foods for blood sugar regulation

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome. In a new study published in the American Journal of Clinical Nutrition, Dr. Mario Kratz, an associate professor …

Fred Hutch statement on the interim analysis of the Phase 3 trial of the Moderna vaccine against COVID-19

Dr. Larry Corey, virologist at Fred Hutchinson Cancer Research Center and co-leader of the COVID-19 Prevention Network’s vaccine testing program, commented on an interim analysis of the Phase 3 trial of the Moderna vaccine against COVID-19: We’re optimistic today about the success of the two mRNA v…

Fred Hutch statement on Phase 3 vaccine interim analysis of Pfizer/ BioNTech vaccine candidate

Dr. Larry Corey, virologist at Fred Hutchinson Cancer Research Center and co-leader of the COVID-19 Prevention Network’s vaccine testing program, commented on early results from the Pfizer and BioNTech Phase 3 vaccine candidate against COVID-19: This is a momentous day for science, and we congrat…

Fred Hutch begins experimental COVID-19 vaccine efficacy trial

Fred Hutchinson Cancer Research Center is starting volunteer enrollment for a COVID-19 vaccine trial. The phase 3 study will examine whether AstraZeneca’s AZD1222 vaccine can protect against COVID-19 and also prevent infection with SARS-CoV-2, the virus responsible for the COVID-19 disease.
Show more

Fred Hutchinson Cancer Research Center Frequently Asked Questions

  • When was Fred Hutchinson Cancer Research Center founded?

    Fred Hutchinson Cancer Research Center was founded in 1975.

  • Who are Fred Hutchinson Cancer Research Center key executives?

    Fred Hutchinson Cancer Research Center's key executives are Niki Robinson, Thomas J. Lynch and Kathy Surace-Smith.

  • How many employees does Fred Hutchinson Cancer Research Center have?

    Fred Hutchinson Cancer Research Center has 4,474 employees.

  • What is Fred Hutchinson Cancer Research Center revenue?

    Latest Fred Hutchinson Cancer Research Center annual revenue is $714 m.

  • What is Fred Hutchinson Cancer Research Center revenue per employee?

    Latest Fred Hutchinson Cancer Research Center revenue per employee is $159.6 k.

  • Who are Fred Hutchinson Cancer Research Center competitors?

    Competitors of Fred Hutchinson Cancer Research Center include Chronix Biomedical, Isoray and BioNTech.

  • Where is Fred Hutchinson Cancer Research Center headquarters?

    Fred Hutchinson Cancer Research Center headquarters is located at 1100 Fairview Ave N j5, Seattle.

  • Where are Fred Hutchinson Cancer Research Center offices?

    Fred Hutchinson Cancer Research Center has offices in Seattle, Cape Town and Kampala.

  • How many offices does Fred Hutchinson Cancer Research Center have?

    Fred Hutchinson Cancer Research Center has 6 offices.